CXCL12 and neoplasm: From a clinicopathological perspective, reduced mRNA expression levels of CXCL12, CXCR4, and CXCR7 in tumor tissues were significantly associated with adverse tumor characteristics, including increased tumor size, local invasion, poor histological differentiation, advanced tumor stage, nodal involvement, and lymphovascular invasion.